While some clinics may offer it as an injection or even orally, most research on GHK-Cu has utilized topical delivery
Q&A with John Bothmer, Clinical Translation Medicine Fellow at Angelini Pharma To further explore the scientific, regulatory and operational complexity behind FirstinHuman trials , we spoke with John Bothmer, Clinical Translation Medicine Fellow within the Global Clinical Development & Clinical Operations department at Angelini Pharma , about the role these studies play in clinical development and the safeguards that support this transition from preclinical research to human investigation
LSE: AZ) is ranked sixth in this report on the basis of its large overall pharmaceutical scale, its co-development of Tezspire (tezepelumab, a thymic stromal lymphopoietin targeting biologic with peptide-like mechanism) with Amgen, and its legacy GLP-1 exposure through exenatide (Bydureon)
As a specialist knee surgeon in Sydney, Dr Jonathan Negus is comfortable having open conversations about emerging treatments and where they currently fit in evidence-based knee care